Barrett Elizabeth A.
CIK 0001764157
Chief Executive OfficerDirector
Filings
13
Latest Feb 19, 2026
Issuers covered
3
Showing
13 of 13
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 100% | +21.5% | +21.4% | +21.7% | +21.4% |
| 90 days | 3 | 100% | +11.0% | +13.7% | +13.7% | +5.4% |
| 180 days | 3 | 100% | +5.8% | +3.6% | +10.0% | +3.6% |
| 365 days | 3 | 33% | -22.0% | -34.6% | +3.1% | -34.6% |
Issuers
Companies where Barrett Elizabeth A. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| URGN | Urogen Pharma Ltd. | 7 | Feb 19, 2026 |
| ALLO | Allogene Therapeutics, Inc. | 4 | Jun 23, 2025 |
| SAGE | Sage Therapeutics, Inc. | 2 | Jul 31, 2025 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|